Effectiveness of bivalirudin as a replacement for heparin during cardiopulmonary bypass in patients undergoing coronary artery bypass grafting

American Journal of Cardiology - Tập 93 - Trang 356-359 - 2004
Andreas Koster1, Bruce Spiess2, Derek P. Chew3, Thomas Krabatsch4, Luc Tambeur4, Abe DeAnda5, Roland Hetzer4, Hermann Kuppe1, Nicholas G. Smedira6, A.Michael Lincoff7
1Department of Anesthesia, Berlin, Germany
2Department of Cardiothoracic Anesthesia, Richmond, Virginia, USA
3Department of Cardiology, Flinders Medical Center, South Australia, Australia
4Department of Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum Berlin, Germany
5Department of Cardiothoracic Surgery, Virginia Commonwealth University, Richmond, Virginia, USA
6Department of Cardiothoracic Surgery, Cleveland, Ohio, USA
7Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio, USA

Tài liệu tham khảo

Lincoff, 2003, Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention, JAMA, 289, 853, 10.1001/jama.289.7.853 Bates, 2000, The mechanism of action of direct thrombin inhibitors, J Invasive Cardiol, 12, 1F Koster, 2003, Bivalirudin monitored with the ecarin clotting time during cardiopulmonary bypass, Anesth Analg, 96, 383, 10.1213/00000539-200302000-00015 Koster, 2003, An assessment of different filter systems for extracorporeal elimination of bivalirudin, Anesth Analg, 96, 1316, 10.1213/01.ANE.0000057605.61063.55 Mangano, 2002, Aspirin and mortality from coronary bypass surgery, N Engl J Med, 347, 1309, 10.1056/NEJMoa020798